Article
A Prospective Study Evaluating Metabolic Capacity of Thiopurine and Associated Adverse Reactions in Japanese Patients with Inflammatory Bowel Disease (IBD).
PloS one - 1 Jan 2015
Odahara Shunichi, Uchiyama Kan, Kubota Takahiro, Ito Zensho, Takami Shinichiro, Kobayashi Hiroko, Saito Keisuke, Koido Shigeo, Ohkusa Toshifumi
Abstract excerpt
Azathioprine (AZA) is frequently used in patients with inflammatory bowel disease (IBD). However, toxic adverse reactions frequently develop and limit the clinical benefits. Currently, the precise mechanisms underlying thiopurine-related toxicity are not well understood. To investigate the relationship between the extent of thiopurine metabolism and adverse reactions in Japanese IBD patients, we prospectively...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
